These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 29550331
1. Hydroxychavicol, a key ingredient of Piper betle induces bacterial cell death by DNA damage and inhibition of cell division. Singh D, Narayanamoorthy S, Gamre S, Majumdar AG, Goswami M, Gami U, Cherian S, Subramanian M. Free Radic Biol Med; 2018 May 20; 120():62-71. PubMed ID: 29550331 [Abstract] [Full Text] [Related]
2. Phytochemical Analysis, Identification and Quantification of Antibacterial Active Compounds in Betel Leaves, Piper betle Methanolic Extract. Syahidah A, Saad CR, Hassan MD, Rukayadi Y, Norazian MH, Kamarudin MS. Pak J Biol Sci; 2017 May 20; 20(2):70-81. PubMed ID: 29022997 [Abstract] [Full Text] [Related]
8. Inhibitory potential of Hydroxychavicol on Ehrlich ascites carcinoma model and in silico interaction on cancer targets. Hemamalini V, Velayutham DPM, Lakshmanan L, Muthusamy K, Sivaramakrishnan S, Premkumar K. Nat Prod Res; 2020 Jun 20; 34(11):1591-1596. PubMed ID: 30470141 [Abstract] [Full Text] [Related]
9. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ali I, Khan FG, Suri KA, Gupta BD, Satti NK, Dutt P, Afrin F, Qazi GN, Khan IA. Ann Clin Microbiol Antimicrob; 2010 Feb 03; 9():7. PubMed ID: 20128889 [Abstract] [Full Text] [Related]
10. A new hydroxychavicol dimer from the roots of Piper betle. Lin CF, Hwang TL, Chien CC, Tu HY, Lay HL. Molecules; 2013 Feb 26; 18(3):2563-70. PubMed ID: 23442932 [Abstract] [Full Text] [Related]
11. Anticancer Potential of Hydroxychavicol Derived from Piper betle L: An in Silico and Cytotoxicity Study. Vinusri S, Gnanam R, Caroline R, Santhanakrishnan VP, Kandavelmani A. Nutr Cancer; 2022 Feb 26; 74(10):3701-3713. PubMed ID: 35703834 [Abstract] [Full Text] [Related]
13. Antibacterial, antibiofilm, and anti-adhesion activities of Piper betle leaf extract against Avian pathogenic Escherichia coli. Kulnanan P, Chuprom J, Thomrongsuwannakij T, Romyasamit C, Sangkanu S, Manin N, Nissapatorn V, de Lourdes Pereira M, Wilairatana P, Kitpipit W, Mitsuwan W. Arch Microbiol; 2021 Dec 21; 204(1):49. PubMed ID: 34935071 [Abstract] [Full Text] [Related]
14. Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes. Biswas P, Anand U, Saha SC, Kant N, Mishra T, Masih H, Bar A, Pandey DK, Jha NK, Majumder M, Das N, Gadekar VS, Shekhawat MS, Kumar M, Radha, Proćków J, Lastra JMP, Dey A. J Cell Mol Med; 2022 Jun 21; 26(11):3083-3119. PubMed ID: 35502487 [Abstract] [Full Text] [Related]
15. Screening of growth inhibitors for epithelial-mesenchymal transition-induced cells by TGF-β from plant-based sources identified the active compound hydroxychavicol from Piper bitle. Matsuo H, Kawakami H, Anjiki N, Kawano N, Fuchino H, Kawahara N, Yoshimatsu K. J Nat Med; 2024 Jun 21; 78(3):774-783. PubMed ID: 38418720 [Abstract] [Full Text] [Related]
16. The new ether derivative of phenylpropanoid and bioactivity was investigated from the leaves of Piper betle L. Atiya A, Sinha BN, Lal UR. Nat Prod Res; 2020 Mar 21; 34(5):638-645. PubMed ID: 30169967 [Abstract] [Full Text] [Related]
17. Piper betle (L): Recent Review of Antibacterial and Antifungal Properties, Safety Profiles, and Commercial Applications. Nayaka NMDMW, Sasadara MMV, Sanjaya DA, Yuda PESK, Dewi NLKAA, Cahyaningsih E, Hartati R. Molecules; 2021 Apr 16; 26(8):. PubMed ID: 33923576 [Abstract] [Full Text] [Related]
19. In silico molecular docking for assessing anti-fungal competency of hydroxychavicol, a phenolic compound of betel leaf (Piper betle L.) against COVID-19 associated maiming mycotic infections. Sekar V, Ramasamy G, Ravikumar C. Drug Dev Ind Pharm; 2022 May 16; 48(5):169-188. PubMed ID: 35311433 [Abstract] [Full Text] [Related]
20. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Chang MC, Uang BJ, Tsai CY, Wu HL, Lin BR, Lee CS, Chen YJ, Chang CH, Tsai YL, Kao CJ, Jeng JH. Br J Pharmacol; 2007 Sep 16; 152(1):73-82. PubMed ID: 17641677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]